---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-21-000066"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2021-08-17T23:59:59+00:00"
generated_at: "2026-06-29T09:31:39.755369+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BioRestorative Therapies shareholders approve reverse stock split, reject Nevada reincorporation

## Summary
- Elected Nickolay Kukekov as Class I director: 1.49B for, 132.6M withheld, 452M broker non-votes.
- Approved 2021 Stock Incentive Plan: 1.33B for, 210M against, 80.8M abstentions.
- Rejected reincorporation from Delaware to Nevada: 1.48B for but 4.4M abstentions, needed majority; broker non-votes 452M.
- Authorized Board to effect reverse stock split at ratio 1:20 to 1:4000 with discretion; 1.65B for, 396M against.
- Ratified Friedman LLP as auditor for FY2021: 1.93B for, 90.2M against, 50M abstentions.

## SEC filing metadata
- accession: 0001021771-21-000066
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2021-08-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177121000066/0001021771-21-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177121000066/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-21-000066
- JSON: https://secwatch.observer/filing/0001021771-21-000066.json
- Plain text: https://secwatch.observer/filing/0001021771-21-000066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.